Imeglimin Hydrochloride works through a dual mechanism of action involving both pancreatic and extra-pancreatic effects. It improves mitochondrial function, which plays a key role in glucose metabolism.

• Enhances glucose-dependent insulin secretion from pancreatic beta cells

• Improves insulin sensitivity in peripheral tissues such as muscle and liver

• Reduces hepatic glucose production

• Protects beta-cell function by reducing oxidative stress and apoptosis

Unlike some traditional antidiabetic drugs, Imeglimin does not overstimulate insulin release, thereby lowering the risk of hypoglycemia. Its mechanism complements other antidiabetic agents, making it suitable for combination therapy.

Imeglimin is well absorbed after oral administration and is primarily eliminated unchanged through the kidneys.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Trimlin Tablet 500 mg is indicated for:

• Treatment of type 2 diabetes mellitus in adults

• Improvement of glycemic control as monotherapy when diet and exercise alone are insufficient

• Combination therapy with other oral antidiabetic drugs or insulin when additional glucose control is required

Dosage & Administration

• The usual recommended dose is 500 mg twice daily, taken orally with meals

• The dose may be adjusted by the physician based on glycemic response and tolerability

• Tablets should be swallowed whole with water

Patients should follow dietary and lifestyle recommendations along with pharmacotherapy for optimal results.

Contraindications

• Hypersensitivity to Imeglimin or any component of the formulation

• Severe renal impairment

• Diabetic ketoacidosis

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Side Effects

Trimlin Tablet is generally well tolerated. The most commonly reported side effects are mild to moderate and may include:

• Nausea

• Diarrhea

• Abdominal discomfort

• Flatulence

These gastrointestinal effects are usually transient and decrease with continued treatment.

Precautions & Warnings

• Renal function should be assessed before initiating therapy and monitored periodically

• Use with caution in patients with moderate renal impairment

• Trimlin Tablet should not replace insulin in insulin-dependent patients

• Hypoglycemia is uncommon when used alone but may occur when combined with other glucose-lowering agents

Pregnancy & Lactation

The safety of Imeglimin during pregnancy and breastfeeding has not been fully established. Trimlin Tablet should be used only if the potential benefit justifies the potential risk, under medical supervision.

Storage Conditions

Store in a cool, dry place below 30°C, protected from moisture and direct sunlight. Keep out of reach of children.